//
Prevalence and Prognosis of Unrecognized Myocardial Infarction Determined by Cardiac Magnetic Resonance in Older Adults
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study
From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes
Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment The EARLY Randomized Trial
Healed Culprit Plaques in Patients With Acute Coronary Syndromes